Alyeska Investment Group’s Orchestra BioMed OBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.25M Hold
1,000,000
0.01% 490
2025
Q4
$4.15M Sell
1,000,000
-365,482
-27% -$1.47M 0.01% 476
2025
Q3
$3.39M Buy
+1,365,482
New +$3.77M 0.01% 480
2022
Q3
Sell
-25,000
Closed -$249K 453
2022
Q2
$249K Hold
25,000
﹤0.01% 544
2022
Q1
$248K Hold
25,000
﹤0.01% 563
2021
Q4
$252K Hold
25,000
﹤0.01% 582
2021
Q3
$247K Hold
25,000
﹤0.01% 655
2021
Q2
$255K Hold
25,000
﹤0.01% 678
2021
Q1
$280K Hold
25,000
﹤0.01% 698
2020
Q4
$320K Sell
25,000
-200
-0.8% -$2.28K ﹤0.01% 468
2020
Q3
$277K Buy
+25,200
New +$283K ﹤0.01% 438

Other funds holding OBIO